Alpha Cognition Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Alpha Cognition Inc. (ACOG) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Alpha Cognition Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$14.04K, a 101.09% decline year-over-year.
- Alpha Cognition Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.08M, a 560.45% increase year-over-year.
- Alpha Cognition Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $566.52K, a 160.95% increase year-over-year.
- Alpha Cognition Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $467.24K, a 20.78% increase year-over-year.
- Alpha Cognition Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.49M, a 270.81% increase from fiscal 2024.
- Alpha Cognition Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $671.72K, a 472.79% increase from fiscal 2023.
- Alpha Cognition Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $117.27K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$14.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.07M 10-Q · filed 2026-08-13 | $1.64M derived: sum of 3 quarters · filed 2026-08-13 | $2.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.08M 10-Q · filed 2026-05-14 | $1.65M derived: sum of 2 quarters · filed 2026-05-14 | $2.12M derived: sum of 3 quarters · filed 2026-05-14 | $3.41M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $566.52K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.03M derived: sum of 2 quarters · filed 2026-03-31 | $2.33M derived: sum of 3 quarters · filed 2026-08-13 | $2.49M 10-K · filed 2026-03-31 |
| 2025-09-30 | $467.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.76M derived: sum of 2 quarters · filed 2026-08-13 | $1.92M 10-Q · filed 2025-11-13 | $2.14M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.46M 10-Q · filed 2026-08-13 | $1.67M derived: sum of 3 quarters · filed 2026-08-13 | $2.06M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $163.95K 10-Q · filed 2026-05-14 | $381.05K derived: sum of 2 quarters · filed 2026-05-14 | $767.90K derived: sum of 3 quarters · filed 2026-05-14 | $622.23K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $217.10K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $603.95K derived: sum of 2 quarters · filed 2026-03-31 | $458.28K derived: sum of 3 quarters · filed 2026-03-31 | $671.72K 10-K · filed 2026-03-31 |
| 2024-09-30 | $386.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $241.18K derived: sum of 2 quarters · filed 2025-11-13 | $454.62K 10-Q · filed 2025-11-13 | $640.65K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$145.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $67.77K 10-Q · filed 2025-08-14 | $253.80K derived: sum of 3 quarters · filed 2025-08-14 | $312.15K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $213.44K 10-Q · filed 2025-05-15 | $399.47K derived: sum of 2 quarters · filed 2025-05-15 | $457.82K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $186.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $244.38K derived: sum of 2 quarters · filed 2025-03-31 | $117.27K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $58.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$68.76K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$127.11K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |